Home/Filings/4/0000897069-24-000395
4//SEC Filing

Bay Shore Trust 4

Accession 0000897069-24-000395

CIK 0001971532other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:11 PM ET

Size

12.2 KB

Accession

0000897069-24-000395

Insider Transaction Report

Form 4
Period: 2024-02-13
Transactions
  • Purchase

    Common Stock

    2024-02-13$7.00/sh+49,000$343,0005,455,431 total(indirect: By Trust)
  • Purchase

    Common Stock

    2024-02-13$7.00/sh+40,000$280,0001,365,646 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2024-02-13$7.00/sh+49,000$343,0001,902,659 total(indirect: By Trust)
Holdings
  • Common Stock

    24,391
  • Common Stock (right to buy)

    (indirect: By Trust)
    Exercise: $3.73From: 2023-06-15Exp: 2028-06-15Common Stock (2,439,025 underlying)
    2,439,025
Transactions
  • Purchase

    Common Stock

    2024-02-13$7.00/sh+49,000$343,0005,455,431 total(indirect: By Trust)
  • Purchase

    Common Stock

    2024-02-13$7.00/sh+40,000$280,0001,365,646 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2024-02-13$7.00/sh+49,000$343,0001,902,659 total(indirect: By Trust)
Holdings
  • Common Stock

    24,391
  • Common Stock (right to buy)

    (indirect: By Trust)
    Exercise: $3.73From: 2023-06-15Exp: 2028-06-15Common Stock (2,439,025 underlying)
    2,439,025
Footnotes (4)
  • [F1]These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F2]These securities are owned directly by the MIRALOGX, LLC, of which the Trust holds all of the membership interests, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F3]These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.
  • [F4]These securities are owned directly by Mr. McNulty.

Documents

1 file

Issuer

Telomir Pharmaceuticals, Inc.

CIK 0001971532

Entity typeother

Related Parties

1
  • filerCIK 0001986593

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:11 PM ET
Size
12.2 KB